Author

T. Fojo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Basseville· 1 shared B. I. Sikic· 1 shared C. Damoci· 1 shared D. Romo· 1 shared D. V. Morales· 1 shared G. E. Duran· 1 shared H. Xue· 1 shared J.-P. Jaffrezou· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Basseville

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma

M. Safari, L. Scotto, A. Basseville, T. Litman, H. Xue, L. Petrukhin, P. Zhou, D. V. Morales, C. Damoci, M. Zhu, K. Hull, K. P. Olive, T. Fojo, D. Romo, S. E. Bates

This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.

bioRxiv · Jun 30, 2024Cancer Biology

The Genomic Stability at the Coding Regions of the Multidrug Transporter Gene ABCB1: Insights into the Development of Alternative Drug Resistance Mechanisms in Human Leukemia Cells

K. G. Chen, G. E. Duran, M. J. Mogul, Y. C. Wang, K. L. Ross, J.-P. Jaffrezou, L. M. Huff, T. Fojo, N. J. Lacayo, B. I. Sikic

This study develops drug-resistant leukemia cell lines to investigate the mechanisms of cyclosporine's effect on multidrug resistance, finding that ABCB1 remains genetically stable and non-P-gp mechanisms contribute to resistance.

bioRxiv · Oct 28, 2019Cancer Biology